8-K: Xtant Medical Sets 2025 Annual Meeting Date
Annual Meeting Announcement
Xtant Medical Holdings, Inc. announced November 7, 2025, as the date for its 2025 Annual Meeting of Stockholders, establishing new deadlines for stockholder proposals and director nominations.
Summary
- The Board of Directors of Xtant Medical Holdings, Inc. established November 7, 2025, as the date for the company's 2025 Annual Meeting of Stockholders.
- The exact time and location of the meeting will be specified in the company's proxy statement.
- The proxy statement is anticipated to be printed on or about September 12, 2025, and sent or made available to stockholders commencing on or about September 15, 2025.
- Due to the change in the Annual Meeting date by more than 30 days from last year's meeting, new deadlines for stockholder proposals have been set.
- Stockholders wishing to present proposals for inclusion in proxy materials under Rule 14a-8 must submit them by the close of business on August 18, 2025.
- Other stockholder proposals, including director nominations, must be submitted in writing to the Corporate Secretary by the close of business on August 18, 2025, in accordance with the company's Bylaws.
- Stockholders intending to solicit proxies for director nominees other than the company's nominees must comply with universal proxy rules (Rule 14a-19) and provide written notice by September 8, 2025.
Sentiment
Score: 5
Explanation: The filing is purely administrative, announcing the date of the annual meeting and associated deadlines. It contains no information that would indicate a positive or negative sentiment regarding the company's performance or outlook.
Future Outlook
This filing is administrative and does not contain forward-looking statements regarding financial performance or strategic business operations. It outlines the procedural timeline for the upcoming annual meeting.
Management Comments
- The report was signed by Sean E. Browne, President and Chief Executive Officer of Xtant Medical Holdings, Inc.
Industry Context
This announcement is a standard administrative disclosure required by publicly traded companies to inform stockholders about their annual meeting and associated deadlines. It does not reflect specific industry trends or competitive positioning but is a routine corporate governance event.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Annual Meeting Date Setting | The Board of Directors established November 7, 2025, as the date for the 2025 Annual Meeting of Stockholders. | 2025-08-08 | Sets the official date for the annual shareholder gathering, which is a fundamental aspect of corporate governance. |
| Stockholder Proposal Deadlines | New deadlines were set for stockholder proposals due to the change in the Annual Meeting date by more than 30 days from the previous year. Proposals under Rule 14a-8 and other proposals/director nominations must be submitted by August 18, 2025. | 2025-08-08 | Ensures compliance with SEC rules and company bylaws for stockholder engagement, requiring stockholders to adhere to updated timelines for submitting proposals or nominations. |
| Universal Proxy Rule Compliance | Stockholders intending to solicit proxies for non-company director nominees must comply with Rule 14a-19 and provide written notice by September 8, 2025. | 2025-08-08 | Clarifies the procedural requirements for proxy solicitations, promoting transparency and fair process in director elections. |
Stakeholder Impact
- Shareholders: Must be aware of the new deadlines for submitting proposals or director nominations for the 2025 Annual Meeting.
- Management/Board: Responsible for preparing and distributing proxy materials and conducting the Annual Meeting according to the established timeline and rules.
Next Steps
- Printing and mailing/making available the proxy statement for the 2025 Annual Meeting on or about September 12, 2025, and September 15, 2025, respectively.
- Holding the 2025 Annual Meeting of Stockholders on November 7, 2025.
Key Dates
| Date | Description |
|---|---|
| 2025-08-08 | Date of the Current Report on Form 8-K and the Board's establishment of the 2025 Annual Meeting date. |
| 2025-08-18 | Deadline for stockholder proposals under Rule 14a-8 and other stockholder proposals/director nominations (advance notice) to be received by the company. |
| 2025-09-08 | Deadline for stockholders to provide written notice for soliciting proxies in support of director nominees other than the company's nominees, as per universal proxy rules (Rule 14a-19). |
| 2025-09-12 | On or about date for anticipated printing of the proxy statement for the 2025 Annual Meeting. |
| 2025-09-15 | On or about date for anticipated mailing or making available of the proxy statement to stockholders. |
| 2025-11-07 | Date of the 2025 Annual Meeting of Stockholders. |
Keywords
Xtant Medical, XTNT, Annual Meeting, Stockholder Proposals, Director Nominations, Proxy Statement, Corporate Governance, SEC Filing, 8-K
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.